跳至主要内容
临床试验/IRCT201311103690N4
IRCT201311103690N4已完成2 期

Comparison the microbiological effects of sustain released microspherical minocycline and emdogain in the non-surgical treatment of peri-implant mucosal inflammation

Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • - Adults aged 18 years and older
  • - Patients with peri-implant inflammation, defined as: Presence of bleeding on probing, probing depth more than 4mm, lack of soft tissue recession, radio-graphic bone loss less than 2mm.
  • - Implant functioning for at least one year
  • Exclusion criteria:
  • - Taking systemic or local antibiotics in the past 3 months
  • - Regular intake of anti-inflammatory drugs in the past 3 months
  • - Any intervention for treatment of peri-implant inflammation in the past 3 months
  • - Poor oral hygiene
  • - Long term treatment with any medication that affects soft and hard tissue conditions (such as phenytoin, cyclosporin, calcium canal blockers...)
  • - Pregnancy and lactation
  • - Sever periodontal disease
  • - Uncontrolled diabetes or debilitating systemic disease
  • - Drug and alcohol addiction
  • - Allergy to tetracycline-class drug(s)

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences

相似试验